Delix Therapeutics, a clinical-stage neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological disorders, today announced full results from the ...
"The synapse is a therapeutic target, and we are determined to communicate our novel findings on the unique pharmacology of modulating synapses. Our new research presented at ACNP this week can help ...